Company / Shareholders' Equity
Enovis Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.5B
FY2025
5-year range
$1.5B / $4.6B
FY2021-FY2025
Trend
-41.9%
vs FY2024
Sector context
#69 of 161
Health Care
What the data says
At $1.5B, Enovis's shareholders' equity ranks #69 of 161 in the Health Care sector. Shareholders' Equity has declined for 4 consecutive years, from $4.6B in FY2021 to $1.5B in FY2025.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of -15.9%.
Declined from $3.4B to $1.5B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -24.4%
- 5-Year CAGR
- -15.9%
- 10-Year CAGR
- -
Sector benchmark
#69 of 161 in Health CareTop 43% of 161This company $1.5B Sector average $5.1B
▼
-70.6% below sector average
Key checks
Key Insights
- Enovis's shareholders' equity has declined for 4 consecutive years.
- 5-year CAGR of -15.9%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 41.9% year-over-year.
- Ranks #69 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | -41.9% |
| FY2024 | $2.6B | -25.0% |
| FY2023 | $3.4B | -0.9% |
| FY2022 | $3.4B | -25.3% |
| FY2021 | $4.6B | +30.3% |
| FY2020 | $3.5B | +3.0% |
| FY2019 | $3.4B | -1.0% |
| FY2018 | $3.5B | -0.7% |
| FY2017 | $3.5B | +20.8% |
| FY2016 | $2.9B | -5.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026